Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Medivation

Biotech & Life Sciences · San Francisco, United States · Founded 2003 Decacorn

Biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases

Valuation
$14B
Market cap · 2026
Revenue
$1.42B
Latest reported FY

Global footprint

Where Medivation has talent and traffic

Workforce by country
4 countries with
team presence
🇺🇸 United States81.5%
🇨🇱 Chile11.1%
🇰🇪 Kenya3.7%
🇦🇷 Argentina3.7%
4 countries shown

Patent intelligence

$90M patent portfolio · 30 active families

Estimated portfolio value
$90M
0.64% of market cap · 8.7× smaller than top peer BioNTech ($780M)
30 active patent families
Where Medivation innovates MedicinePharmaceutical drugPharmacologySurgical deviceSurgical instrument

Where Medivation concentrates vs peers

Each axis is a top-10 topic across Medivation and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Medivation

An AI-synthesized read of the highest-engagement posts about Medivation on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medivation on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.